[{"address1": "6272 West 91st Avenue", "city": "Westminster", "state": "CO", "zip": "80031", "country": "United States", "phone": "303 442 1222", "website": "https://trisaluslifesci.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Mary T. Szela B.S.N., M.B.A.", "age": 60, "title": "CEO, President & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 880671, "exercisedValue": 0, "unexercisedValue": 2889837}, {"maxAge": 1, "name": "Mr. Sean Edward Murphy", "age": 71, "title": "Chief Manufacturing, Strategy & Business Development Officer and Director", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 628747, "exercisedValue": 0, "unexercisedValue": 315273}, {"maxAge": 1, "name": "Mr. James E. Young", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lori Ann Santamaria", "title": "Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Stevens J.D.", "age": 62, "title": "Chief Regulatory Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 629995, "exercisedValue": 0, "unexercisedValue": 22290}, {"maxAge": 1, "name": "Dr. Richard B. Marshak M.B.A., MBA, VMD", "age": 65, "title": "Chief Commercial Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jodi  Devlin", "age": 61, "title": "Chief of Clinical Strategy & Operations", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bryan F. Cox Ph.D.", "age": 62, "title": "Chief of Research", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.2, "open": 0.4201, "dayLow": 0.4201, "dayHigh": 1.2877, "regularMarketPreviousClose": 1.2, "regularMarketOpen": 0.4201, "regularMarketDayLow": 0.4201, "regularMarketDayHigh": 1.2877, "beta": 0.489, "volume": 573, "regularMarketVolume": 573, "averageVolume": 2953, "averageVolume10days": 860, "averageDailyVolume10Day": 860, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.42, "fiftyTwoWeekHigh": 2.24, "fiftyDayAverage": 1.42272, "twoHundredDayAverage": 1.28807, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": -1.02086, "floatShares": 22187946, "bookValue": -0.828, "netIncomeToCommon": -33233000, "52WeekChange": 0.26086962, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 1.16, "recommendationKey": "none", "totalCash": 8525000, "totalCashPerShare": 0.273, "ebitda": -35430336, "totalDebt": 23629000, "quickRatio": 1.331, "currentRatio": 2.021, "totalRevenue": 29431000, "revenuePerShare": 1.162, "returnOnAssets": -0.90966004, "grossProfits": 25328000, "revenueGrowth": 0.444, "grossMargins": 0.86059, "ebitdaMargins": -1.20384, "operatingMargins": -0.91756, "financialCurrency": "USD", "symbol": "TLSIW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -3.33334, "regularMarketPrice": 1.16, "corporateActions": [], "regularMarketTime": 1744401600, "exchange": "NGM", "messageBoardId": "finmb_119056665", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612881000000, "regularMarketChange": -0.04000008, "regularMarketDayRange": "0.4201 - 1.2877", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2953, "fiftyTwoWeekLowChange": 0.74, "fiftyTwoWeekLowChangePercent": 1.7619048, "fiftyTwoWeekRange": "0.42 - 2.24", "fiftyTwoWeekHighChange": -1.08, "fiftyTwoWeekHighChangePercent": -0.48214287, "fiftyTwoWeekChangePercent": 26.086962, "fiftyDayAverageChange": -0.26272, "fiftyDayAverageChangePercent": -0.18466036, "twoHundredDayAverageChange": -0.12807, "twoHundredDayAverageChangePercent": -0.09942783, "priceToBook": -1.4009662, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "longName": "TriSalus Life Sciences, Inc.", "displayName": "TriSalus Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]